Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Patients receiving short protocol IVF/ICSI-treatment. (drug)
• Long protocol (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Dronninglund Fertility Clinic
  Dronninglund, Denmark
  Site recruitment: Not reported
• Fertility Clinic, Hvidovre Hospital
  Hvidovre, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Acyline (drug) — also listed as: Acyline GhRH antagonist
• placebo hCG (no active ingredient) (other) — also listed as: placebo drug
• hCG (human chorionic gonadotropin) (drug) — also listed as: Pregnyl
• hCG (human chorionic gonadotropin) (drug) — also listed as: Pregnyl
• hCG (human chorionic gonadotropin) (drug) — also listed as: Pregnyl
• Testosterone gel (drug) — also listed as: Testim

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Washington
  Seattle, Washington, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• FSH 225IU and hMG 225IU (drug)
• FSH 150IU and hMG 150IU (drug)
• Letrozole 5mg and hMG 150IU (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Istanbul University School of Medicine
  Istanbul, Turkey (Türkiye)
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Letrozole (drug) — also listed as: Femara
• human menopausal gonadotropin (hMG) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Obstetrics and Gynecology, Istanbul University School of Medicine
  Istanbul, Turkey (Türkiye)
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• hysteroscope (device)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Obstetrics and Gynecology, Shin-Kong Wu-Ho-Su Memerial Hospital
  Taipei, Taiwan
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• MSJ-0011 (drug)
• urinary hCG (u-hCG) (drug)
• Follitropin alpha (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Hanabusa Women's Central Fertility Clinic
  Hyōgo, Japan
  Site recruitment: Not reported
• Bashamichi Ladies Clinic
  Kanagawa, Japan
  Site recruitment: Not reported
• Sophia Ladies Clinic
  Kanagawa, Japan
  Site recruitment: Not reported
• Ivf Namba Clinic
  Osaka, Japan
  Site recruitment: Not reported
• Ivf Osaka Clinic
  Osaka, Japan
  Site recruitment: Not reported
• Department of Obstetrics and Gynecology, Saitama Medical University Hospital
  Saitama, Japan
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Ovarian stimulation in a GnRH-antagonist protocol (drug) — also listed as: Elonva, Puregon, Orgalutran, Predalon, Crinone

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Fertility Center Kiel
  Kiel, S-H, Germany
  Site recruitment: Not reported
• University Hospital of Schleswig-Holstein, Campus Luebeck
  Lübeck, Schleswig-Holstein, Germany
  Site recruitment: Not reported
• Prof. Axel Kamischke
  Münster, Germany
  Site recruitment: Not reported
• Sabine Segerer
  Würzburg, Germany
  Site recruitment: Not reported
• Klinikk Hausken
  Haugesund, Norway
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Human menopausal gonadotrophin (HMG) (drug) — also listed as: Merional®
• GnRH antagonist Cetrorelix (drug) — also listed as: Cetrotide®
• Human chorionic gonadotrophin (hCG) (drug) — also listed as: Choriomon®

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• NO intervention (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• in vitro fertilization (IVF/ICSI) (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• New Hope Fertility Center
  New York, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• LH (drug)
• HCG (drug)
• Clomiphene (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Health Policy Research Center
  Shiraz, Fars, Iran
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• COL-1620 (drug)
• Gonadotropin-releasing hormone (GnRH) analogue (drug)
• Follicle-stimulating hormone (FSH) (drug)
• Human Chorionic Gonadotropin (hCG) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Research site
  Fujimino, Japan
  Site recruitment: Not reported
• Research site
  Kobe, Japan
  Site recruitment: Not reported
• Research site
  Osaka, Japan
  Site recruitment: Not reported
• Research site
  Sagamihara, Japan
  Site recruitment: Not reported
• Research site
  Yokohama, Kanagawa, Japan
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Clearblue Investigational Pregnancy test (other)
• Professional pregnancy test (other)
• Clearblue Marketed Pregnancy test (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Illingworth Research Ltd
  Macclesfield, Chester, United Kingdom
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Human chorionic gonadotrophin (drug)
• Placebo (drug) — also listed as: Normal saline

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• The University of Hong Kong
  Hong Kong, Hong Kong
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Daily monitoring of LH and E2 (procedure)
• hCG induced natural cycle (procedure)
• ultrasound (device)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University
  Guangzhou, China
  Site recruitment: Not reported
• Queen Mary Hospital
  Hong Kong, Hong Kong, Hong Kong
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• 10000 IU urinary HCG (drug) — also listed as: Pregnyl
• 250 mcg recombinant HCG (drug) — also listed as: Ovitrelle

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Centre for Reproductive Medicine, UZ Brussel
  Brussels, Jette, Belgium
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• COOL-COS (drug) — also listed as: Friendly COS

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Setor de Reproducao Humana do HC-FMRP-USP
  Ribeirão Preto, São Paulo, Brazil
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Cabergoline (drug)
• GnRH antagonist rescue & cabergoline (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Aljazeera( Al Gazeera) hospital
  Giza, Giza Governorate, Egypt
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• mild ovarian stimulation (procedure)
• conventional ovarian stimulation (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• 3rd Department of Obstetrics & Gynecology, Assisted Reproduction Unit
  Athens, Chaidari, Greece
  Site recruitment: Not reported